The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Recordati Rare DiseasesEU/1/09/533/1-3

Main Information

Trade NameVedrop
Active SubstancesTocofersolan d-alpha tocopheryl polyethylene glycol 1000 succinate
Dosage FormOral solution
Licence HolderRecordati Rare Diseases
Licence NumberEU/1/09/533/1-3

Group Information

ATC CodeA11HA08 tocofersolan


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back